Nailfold capillaroscopy in primary biliary cirrhosis: A useful tool for the early diagnosis of scleroderma

Journal of Gastrointestinal and Liver Diseases

Volumn 23, Issue 1, 2014, Pages 39-43

  Tovoli, Francesco ^a   Granito, Alessandro ^a   Giampaolo, Luca ^a   Frisoni, Magda ^b   Volta, Umberto ^a   Fusconi, Marco ^a   Masi, Chiara ^a   Lenzi, Marco ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anti; Centromere antibodies; Nailfold capillaroscopy; Primary biliary cirrhosis; Raynaud phenomenon; Systemic sclerosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; CENTROMERE PROTEIN B; GAMMA GLUTAMYLTRANSFERASE; PREDNISONE; URSODEOXYCHOLIC ACID; AUTOANTIBODY;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; CAPILLAROSCOPY; CHRONIC LIVER DISEASE; CLINICAL EVALUATION; CLINICAL FEATURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOFLUORESCENCE TEST; LIVER BIOPSY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; QUANTITATIVE ASSAY; RAYNAUD PHENOMENON; SCLERODERMA; SYSTEMIC SCLEROSIS; VERY ELDERLY; ANGIOSCOPY; AUTOIMMUNE DISEASES; BLOOD; CASE CONTROL STUDY; COMPLICATION; EARLY DIAGNOSIS; IMMUNOLOGY; ITALY; LIVER CIRRHOSIS, BILIARY; MIDDLE AGED; NAIL; PROCEDURES; PROSPECTIVE STUDY; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; VASCULARIZATION; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; EARLY DIAGNOSIS; FEMALE; HUMANS; ITALY; LIVER CIRRHOSIS, BILIARY; MALE; MICROSCOPIC ANGIOSCOPY; MIDDLE AGED; NAILS; PREVALENCE; PROSPECTIVE STUDIES; RAYNAUD DISEASE; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 84897099771     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Lindor KD, Gershwin ME, Poupon R, et al; American Association for Study of Liver Diseases. Primary biliary cirrhosis. Hepatology 2009;50:291-308.
2. Parveen S, Morshed SA, Nishioka M. High prevalence of antibodies to recombinant CENP-B in primary biliary cirrhosis: nuclear immunofluorescence patterns and ELISA reactivities. J Gastroenterol Hepatol 1995;10:438-445.
3. Dörner T, Held C, Trebeljahr G, Lukowsky A, Yamamoto K, Hiepe F. Serologic characteristics in primary biliary cirrhosis associated with sicca syndrome. Scand J Gastroenterol 1994;29:655-660.
4. Chou MJ, Lee SL, Chen TY, Tsay GJ. Specificity of antinuclear antibodies in primary biliary cirrhosis. Ann Rheum Dis 1995;54:148-151.
5. Marasini B, Gagetta M, Rossi V, Ferrari P. Rheumatic disorders and primary biliary cirrhosis: an appraisal of 170 Italian patients. Ann Rheum Dis 2001;60:1046-1049.
6. Watt FE, James OF, Jones DE. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. QJM 2004;97:397-406.
7. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-590.
8. Ferri C, Valentini G, Cozzi F, et al; Systemic Sclerosis Study Group of the Italian Society of Rheumatology (SIR-GSSSc). Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients. Medicine (Baltimore) 2002;81:139-153.
9. Hunzelmann N, Genth E, Krieg T, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008;47:1185-1192.
10. Le Roy EC, Medsger TA Jr. Criteria for the classifiation of early systemic sclerosis. J Rheumatol 2001;28:1573-1576.
11. Koenig M, Joyal F, Fritzler MJ, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud's phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosis. Arthritis Rheum 2008;58:3902-3912.
12. Rigamonti C, Bogdanos DP, Mytilinaiou MG, Smyk DS, Rigopoulou EI, Burroughs AK. Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol 2011;2011:976427.
13. Pares A, Caballeria L, Rodes J. Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterology 2006;130:715-720.
14. Boberg KM, Chapman RW, Hirschfield GM, et al; International Autoimmune Hepatitis Group. Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 2011;54:374-385.
15. Roberts EA, Schilsky ML; American Association for Study of Liver Diseases (AASLD). Diagnosis and treatment of Wilson disease: an update. Hepatology 2008;47:2089-2111.
16. Clark JM, Diehl AM. Nonalcoholic fatty liver disease: an underrecognized cause of cryptogenic cirrhosis. JAMA 2003;289:3000-3004.
17. LeRoy EC, Medsger TA Jr. Raynaud's phenomenon: a proposal for classification. Clin Exp Rheumatol 1992;10:485-488.
18. Cassani F, Bianchi FB, Lenzi M, Volta U, Pisi E. Immunomorphological characterisation of antinuclear antibodies in chronic liver disease. J Clin Pathol 1985;38:801-805.
19. Granito A, Muratori P, Muratori L, et al. Antinuclear antibodies giving the 'multiple nuclear dots'or the 'rim-like/membranous'patterns: diagnostic accuracy for primary biliary cirrhosis. Aliment Pharmacol Ther 2006;24:1575-1583.
20. Maricq HR. Wide-field capillary microscopy. Arthritis Rheum 1981;24:1159-1165.
21. Granito A, Muratori P, Muratori L, et al. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis. Aliment Pharmacol Ther 2007;26:831-838.
22. Liberal R, Grant CR, Sakkas L, Bizzaro N, Bogdanos DP. Diagnostic and clinical significance of anti-centromere antibodies in primary biliary cirrhosis. Clin Res Hepatol Gastroenterol 2013;37:572-585.
23. Marasini B, Pipia C, DeValle G, et al. Vascular impairment in patients with primary biliary cirrhosis. Int J Microcirc Clin Exp 1995;15:75-79.
24. Fonollosa V, Simeón CP, Castells L, et al. Morphologic capillary changes and manifestations of connective tissue diseases in patients with primary biliary cirrhosis. Lupus 2001;10:628-631.
25. Valentini G, Cuomo G, Abignano G, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) 2011;50:317-323.